Philipp Schwabl Division of Gastroenterology & Hepatology, Department of Internal Medicine III Medical University of Vienna Biography Publications Institution JoVE Articles Philipp Schwabl has not added a biography. If you are Philipp Schwabl and would like to personalize this page please email our Author Liaison for assistance. Publications Non-invasive Detection of Portal Hypertension by Enhanced Liver Fibrosis Score in Patients with Different Aetiologies of Advanced Chronic Liver Disease Liver International : Official Journal of the International Association for the Study of the Liver. May, 2020 | Pubmed ID: 32358998 Novel Reliability Criteria for Controlled Attenuation Parameter Assessments for Non-invasive Evaluation of Hepatic Steatosis United European Gastroenterology Journal. Apr, 2020 | Pubmed ID: 32213023 Iron Deficiency Induced Thrombocytosis Increases Thrombotic Tendency in Rats Haematologica. Feb, 2020 | Pubmed ID: 32079699 Bioimpedance Spectroscopy for Fluid Status Assessment in Patients with Decompensated Liver Cirrhosis: Implications for Peritoneal Dialysis Scientific Reports. Feb, 2020 | Pubmed ID: 32071351 Impact of HSD17B13 Rs72613567 Genotype on Hepatic Decompensation and Mortality in Patients with Portal Hypertension Liver International : Official Journal of the International Association for the Study of the Liver. Feb, 2020 | Pubmed ID: 31967400 Prevalence of and Risk Factors for Anaemia in Patients with Advanced Chronic Liver Disease Liver International : Official Journal of the International Association for the Study of the Liver. Jan, 2020 | Pubmed ID: 31444993 Changes in Hepatic Venous Pressure Gradient Predict Hepatic Decompensation in Patients Who Achieved Sustained Virologic Response to Interferon-Free Therapy Hepatology (Baltimore, Md.). Mar, 2020 | Pubmed ID: 31365764 The Impact of Hepatic Steatosis on Portal Hypertension PloS One. 2019 | Pubmed ID: 31693695 HCV-RNA is Commonly Detectable in Rectal and Nasal Fluids of Patients with High Viremia Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America. Sep, 2019 | Pubmed ID: 31562817 Detection of Various Microplastics in Human Stool: A Prospective Case Series Annals of Internal Medicine. 10, 2019 | Pubmed ID: 31476765 Vascular Targets for the Treatment of Portal Hypertension Seminars in Liver Disease. 11, 2019 | Pubmed ID: 31315135 Ascitic Fluid Polymorphic Nuclear Cell Count Impacts on Outcome of Cirrhotic Patients with Ascites United European Gastroenterology Journal. 06, 2019 | Pubmed ID: 31210943 Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension Digestive Diseases and Sciences. 12, 2019 | Pubmed ID: 31209721 Prevalence and Predictors of Hepatic Steatosis in Patients with HIV/HCV Coinfection and the Impact of HCV Eradication AIDS Patient Care and STDs. 05, 2019 | Pubmed ID: 31067123 High Efficacy of Interferon-free Therapy for Acute Hepatitis C in HIV-positive Patients United European Gastroenterology Journal. 05, 2019 | Pubmed ID: 31065368 Impact of Farnesoid X Receptor Single Nucleotide Polymorphisms on Hepatic Decompensation and Mortality in Cirrhotic Patients with Portal Hypertension Journal of Gastroenterology and Hepatology. Dec, 2019 | Pubmed ID: 31062417 Programmed Cell Death Protein-1 (PD-1)-targeted Immunotherapy in Advanced Hepatocellular Carcinoma: Efficacy and Safety Data from an International Multicentre Real-world Cohort Alimentary Pharmacology & Therapeutics. 05, 2019 | Pubmed ID: 30980420 Transjugular Aspiration Liver Biopsy Performed by Hepatologists Trained in HVPG Measurements is Safe and Provides Important Diagnostic Information Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 08, 2019 | Pubmed ID: 30862438 Controlled Attenuation Parameter Does Not Predict Hepatic Decompensation in Patients with Advanced Chronic Liver Disease Liver International : Official Journal of the International Association for the Study of the Liver. 01, 2019 | Pubmed ID: 30107095 Point Shear Wave Elastography for Non-invasive Assessment of Liver Fibrosis in Patients with Viral Hepatitis Ultrasound in Medicine & Biology. 12, 2018 | Pubmed ID: 30241728 The Soluble Guanylate Cyclase Stimulator Riociguat Reduces Fibrogenesis and Portal Pressure in Cirrhotic Rats Scientific Reports. Jun, 2018 | Pubmed ID: 29921982 Anticoagulation in Non-malignant Portal Vein Thrombosis is Safe and Improves Hepatic Function Wiener Klinische Wochenschrift. Jun, 2018 | Pubmed ID: 29916054 Comparison of Three Cut-offs to Diagnose Clinically Significant Portal Hypertension by Liver Stiffness in Chronic Viral Liver Diseases: a Meta-analysis European Radiology. Dec, 2018 | Pubmed ID: 29858640 Transjugular Intrahepatic Portosystemic Shunts (TIPS) for the Prevention of Variceal Re-bleeding - A Two Decades Experience PloS One. 2018 | Pubmed ID: 29315304 EPTFE-TIPS Vs Repetitive LVP Plus Albumin for the Treatment of Refractory Ascites in Patients with Cirrhosis Liver International : Official Journal of the International Association for the Study of the Liver. 06, 2018 | Pubmed ID: 29091351 Non-invasive Liver Fibrosis Assessment and HCV Treatment Initiation Within A systematic Screening Program in HIV/HCV Coinfected Patients Wiener Klinische Wochenschrift. Feb, 2018 | Pubmed ID: 28744597 Austrian Consensus Guidelines on the Management and Treatment of Portal Hypertension (Billroth III) Wiener Klinische Wochenschrift. Nov, 2017 | Pubmed ID: 29063233 Re-bleeding Rates and Survival After Early Transjugular Intrahepatic Portosystemic Shunt (TIPS) in Clinical Practice Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. Dec, 2017 | Pubmed ID: 28869158 Novel Treatment Options for Portal Hypertension Gastroenterology Report. May, 2017 | Pubmed ID: 28533907 Non-selective Beta-blocker Treatment Does Not Impact on Kidney Function in Cirrhotic Patients with Varices Scandinavian Journal of Gastroenterology. Sep, 2017 | Pubmed ID: 28532189 Progress in Eradication of HCV in HIV Positive Patients with Significant Liver Fibrosis in Vienna Wiener Klinische Wochenschrift. Aug, 2017 | Pubmed ID: 28130599 The FXR Agonist PX20606 Ameliorates Portal Hypertension by Targeting Vascular Remodelling and Sinusoidal Dysfunction Journal of Hepatology. Apr, 2017 | Pubmed ID: 27993716 Metabolic Preconditioning Protects BSEP/ABCB11 Mice Against Cholestatic Liver Injury Journal of Hepatology. Jan, 2017 | Pubmed ID: 27593105 Plasma Renin Concentration Represents an Independent Risk Factor for Mortality and is Associated with Liver Dysfunction in Patients with Cirrhosis Journal of Gastroenterology and Hepatology. Jan, 2017 | Pubmed ID: 27164413 Liver Capsule: FXR Agonists Against Liver Disease Hepatology (Baltimore, Md.). 11, 2016 | Pubmed ID: 27635933 Interferon-free Regimens Improve Health-related Quality of Life and Fatigue in HIV/HCV-coinfected Patients with Advanced Liver Disease: A Retrospective Study Medicine. Jul, 2016 | Pubmed ID: 27399090 Sustained Virologic Response to Interferon-free Therapies Ameliorates HCV-induced Portal Hypertension Journal of Hepatology. 10, 2016 | Pubmed ID: 27242316 The Trigger Matters - Outcome of Hepatorenal Syndrome Vs. Specifically Triggered Acute Kidney Injury in Cirrhotic Patients with Ascites Liver International : Official Journal of the International Association for the Study of the Liver. 11, 2016 | Pubmed ID: 27169985 Prognosis of Cirrhotic Patients with Fungiascites and Spontaneous Fungal Peritonitis (SFP) Journal of Hepatology. 06, 2016 | Pubmed ID: 26916528 Interferon-free Treatment with Sofosbuvir/daclatasvir Achieves Sustained Virologic Response in 100% of HIV/hepatitis C Virus-coinfected Patients with Advanced Liver Disease AIDS (London, England). Apr, 2016 | Pubmed ID: 26760453 Advances in the Management of HIV/HCV Coinfection Hepatology International. May, 2016 | Pubmed ID: 26758592 Treatment Intensification with Boceprevir in HIV-positive Patients with Acute HCV-genotype 1 Infection at High Risk for Treatment Failure Wiener Klinische Wochenschrift. Jun, 2016 | Pubmed ID: 26659706 The Impact of PNPLA3 Rs738409 SNP on Liver Fibrosis Progression, Portal Hypertension and Hepatic Steatosis in HIV/HCV Coinfection PloS One. 2015 | Pubmed ID: 26599080 Impact of Acute Kidney Injury on Prognosis of Patients with Liver Cirrhosis and Ascites: A Retrospective Cohort Study Journal of Gastroenterology and Hepatology. Nov, 2015 | Pubmed ID: 25967931 Circulating MiRNA-122 Levels Are Associated with Hepatic Necroinflammation and Portal Hypertension in HIV/HCV Coinfection PloS One. 2015 | Pubmed ID: 25646812 Risk Factors for Development of Spontaneous Bacterial Peritonitis and Subsequent Mortality in Cirrhotic Patients with Ascites Liver International : Official Journal of the International Association for the Study of the Liver. Sep, 2015 | Pubmed ID: 25644943 Response-guided Boceprevir-based Triple Therapy in HIV/HCV-coinfected Patients: the HIVCOBOC-RGT Study The Journal of Infectious Diseases. Mar, 2015 | Pubmed ID: 25214517 New Reliability Criteria for Transient Elastography Increase the Number of Accurate Measurements for Screening of Cirrhosis and Portal Hypertension Liver International : Official Journal of the International Association for the Study of the Liver. Feb, 2015 | Pubmed ID: 24953516 Revisiting Liver Disease Progression in HIV/HCV-coinfected Patients: the Influence of Vitamin D, Insulin Resistance, Immune Status, IL28B and PNPLA3 Liver International : Official Journal of the International Association for the Study of the Liver. Mar, 2015 | Pubmed ID: 24905495 Proton Pump Inhibitor Intake Neither Predisposes to Spontaneous Bacterial Peritonitis or Other Infections nor Increases Mortality in Patients with Cirrhosis and Ascites PloS One. 2014 | Pubmed ID: 25369194 PRO-C3-levels in Patients with HIV/HCV-Co-infection Reflect Fibrosis Stage and Degree of Portal Hypertension PloS One. 2014 | Pubmed ID: 25265505 Nonselective β Blockers Increase Risk for Hepatorenal Syndrome and Death in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis Gastroenterology. Jun, 2014 | Pubmed ID: 24631577 Nebivolol Treatment Increases Splanchnic Blood Flow and Portal Pressure in Cirrhotic Rats Via Modulation of Nitric Oxide Signalling Liver International : Official Journal of the International Association for the Study of the Liver. Apr, 2013 | Pubmed ID: 23331709 Carvedilol for Primary Prophylaxis of Variceal Bleeding in Cirrhotic Patients with Haemodynamic Non-response to Propranolol Gut. Nov, 2013 | Pubmed ID: 23250049 Sorafenib Attenuates the Portal Hypertensive Syndrome in Partial Portal Vein Ligated Rats Journal of Hepatology. Nov, 2009 | Pubmed ID: 19726100 हेपेटिक वेनस प्रेशर ग्रेडिएंट और ट्रांसजुगुलर लिवर बायोप्सी का मापन Thomas Reiberger1,2, Philipp Schwabl1,2, Michael Trauner1,2, Markus Peck-Radosavljevic2,3, Mattias Mandorfer1,2 1Division of Gastroenterology & Hepatology, Department of Internal Medicine III, Medical University of Vienna, 2Vienna Hepatic Hemodynamic Lab, Medical University of Vienna, 3Department of Internal Medicine and Gastroenterology (IMuG), Klinikum Klagenfurt am Woerthersee JoVE 58819 Medicine पोर्टल के इनवेसिव Hemodynamic लक्षण वर्णन-Cirrhotic चूहों में ग्रस्त सिंड्रोम Philipp Königshofer1,2, Ksenia Brusilovskaya1,2, Philipp Schwabl1,2, Bruno K. Podesser3, Michael Trauner1, Thomas Reiberger1,2 1Div. of Gastroenterology and Hepatology, Dept. of Internal Medicine III, Medical University of Vienna, Vienna, Austria, 2Vienna Hepatic Hemodynamic Laboratory, Medical University of Vienna, Vienna, Austria, 3Center of Biomedical Research, Medical University of Vienna, Vienna, Austria JoVE 57261 Medicine
हेपेटिक वेनस प्रेशर ग्रेडिएंट और ट्रांसजुगुलर लिवर बायोप्सी का मापन Thomas Reiberger1,2, Philipp Schwabl1,2, Michael Trauner1,2, Markus Peck-Radosavljevic2,3, Mattias Mandorfer1,2 1Division of Gastroenterology & Hepatology, Department of Internal Medicine III, Medical University of Vienna, 2Vienna Hepatic Hemodynamic Lab, Medical University of Vienna, 3Department of Internal Medicine and Gastroenterology (IMuG), Klinikum Klagenfurt am Woerthersee JoVE 58819 Medicine
पोर्टल के इनवेसिव Hemodynamic लक्षण वर्णन-Cirrhotic चूहों में ग्रस्त सिंड्रोम Philipp Königshofer1,2, Ksenia Brusilovskaya1,2, Philipp Schwabl1,2, Bruno K. Podesser3, Michael Trauner1, Thomas Reiberger1,2 1Div. of Gastroenterology and Hepatology, Dept. of Internal Medicine III, Medical University of Vienna, Vienna, Austria, 2Vienna Hepatic Hemodynamic Laboratory, Medical University of Vienna, Vienna, Austria, 3Center of Biomedical Research, Medical University of Vienna, Vienna, Austria JoVE 57261 Medicine
